Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy.

scientific article published in August 2000

Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/JMCC.2000.1185
P698PubMed publication ID10900171

P50authorMuthu PeriasamyQ41535997
Junichi SadoshimaQ51313947
Gopal J BabuQ57542258
P2093author name stringM A Sussman
M J Lalli
P433issue8
P921main subjectphosphorylationQ242736
P304page(s)1447-1457
P577publication date2000-08-01
P1433published inJournal of Molecular and Cellular CardiologyQ2061932
P1476titlePhosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy
P478volume32

Reverse relations

cites work (P2860)
Q47137519A model of the onset of the senescence associated secretory phenotype after DNA damage induced senescence
Q48144427Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation
Q41865336Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK.
Q44016918Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases
Q41211026Calcineurin/NFAT Activation-Dependence of Leptin Synthesis and Vascular Growth in Response to Mechanical Stretch
Q58097639Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
Q28572349Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats
Q36509791Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms
Q53558215Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes.
Q38288761Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
Q46024791Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects.
Q38360604Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors
Q37702398Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
Q42055700Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription
Q26800200Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy
Q36563659Genetics of melanoma
Q40565030Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice
Q35058555Kinases as therapeutic targets for heart failure
Q34262273Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase
Q37254485MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Q36192201Mechanical stretch-induced vascular hypertrophy occurs through modulation of leptin synthesis-mediated ROS formation and GATA-4 nuclear translocation
Q35165708Modelling negative feedback networks for activating transcription factor 3 predicts a dominant role for miRNAs in immediate early gene regulation
Q33807091Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?
Q28566976Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility
Q27323042Myeloid zinc finger 1 (Mzf1) differentially modulates murine cardiogenesis by interacting with an Nkx2.5 cardiac enhancer
Q34524445Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation.
Q38897244Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells.
Q33991241Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos induction
Q40289273Role of mitogen-activated protein kinase kinase in Porphyromonas gingivalis-induced myocardial cell hypertrophy and apoptosis
Q36567326Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome
Q36021498Signaling through the extracellular signal-regulated kinase 1/2 cascade in cardiac myocytes
Q44830931TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1.
Q28384049Targeting the MEK1 cascade in lung epithelium inhibits proliferation and fibrogenesis by asbestos
Q35131700Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases
Q38990164The Regulatory Roles of Mitogen-activated Protein Kinase (MAPK) Pathways in Health and Diabetes: Lessons Learned from the Pancreatic β-cell.
Q24321252The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling
Q42504443The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.
Q34235236Vascular dysfunction induced in offspring by maternal dietary fat involves altered arterial polyunsaturated fatty acid biosynthesis
Q53099936miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.

Search more.